Palatin Presents PL8177 Ulcerative Colitis Data at Digestive Disease Week Annual Conference
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
Stay updated with breaking news from Potential Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
Preclinical data shows efficacy in animal models of ulcerative colitisHuman pharmacokinetic data show oral formulation releases PL8177 in colonCRA...
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
Igraine Plc - Unaudited Financial Statements to 31 December 2021 PR Newswire London, June 30 Igraine plc AQSE: KING ("Igraine" or "the company") Unaudited Financial